Conjugation Chemistry-Dependent T-Cell Activation with Spherical Nucleic Acids

Area of Science:

• Immunology
• Nanotechnology
• Bioconjugation Chemistry

Background:

• Spherical nucleic acids (SNAs) are potent immune stimulators.
• SNAs loaded with peptide antigens can train T-cells to target cancer cells.
• The chemical conjugation of peptides to DNA for SNA loading is critical for immune activation.

Purpose of the Study:

• To investigate the role of peptide chemical conjugation in SNA-mediated antigen presentation.
• To evaluate the impact of different linker chemistries on T-cell responses.
• To optimize SNA-based vaccine strategies for enhanced anti-cancer immunity.

Main Methods:

• Synthesis of SNAs with varying peptide conjugation chemistries (noncleavable, cleavable nontraceless, traceless linkers).
• Assessment of Toll-like receptor 9 (TLR-9) regulated antigen-presenting cell (APC) activation.
• Quantification of downstream T-cell activation and proliferation.

Main Results:

• Antigen conjugation chemistry did not impede TLR-9 mediated APC activation.
• The choice of conjugation chemistry significantly augmented T-cell activation and proliferation.
• Traceless linkers resulted in up to an 8-fold improvement in T-cell proliferation compared to other linkers.

Conclusions:

• Peptide conjugation chemistry is a critical factor in the efficacy of SNA-based vaccines.
• Traceless linkers represent a promising strategy for enhancing T-cell responses in cancer immunotherapy.
• This study provides valuable insights for the rational design of next-generation vaccines.